By Christine Powell ( October 8, 2015, 7:25 PM EDT) -- Amicus Therapeutics Inc. misled investors about the prospects of a new drug to treat a rare genetic disease, then reversed course two weeks later and sent stock prices plummeting, a shareholder alleged Wednesday in a proposed class action in New Jersey federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.